Citi Cuts Tech to Neutral, Upgrades Europe
Citi's global strategy team lowered its rating on U.S. and global tech stocks while raising its view on European equities excluding the U.K.
Updated on Nov. 9, 2026 in Stock Picks
Live Poll
Are you planning to move any of your investments out of tech stocks soon?
Citi's global strategy team cut global, U.S., and European tech stocks to neutral and upgraded Europe (ex U.K.) to overweight in a research note published Monday. The bank also upgraded healthcare to overweight and kept materials at overweight.
Why it matters
The Nasdaq is trading at forward valuations last seen in March 2020, and defensive sectors outperformed cyclicals by 15% over the last month. Citi's analysts said earnings forecasts for 2027 have remained steady while stocks corrected.
Citi's research note is a tactical forecast by a major bank's strategy team, with targets for the S&P 500, Topix and MSCI emerging markets indexes compared against current levels of 3,895 and 1,355. The note does not address how long the defensive rotation will last or what would trigger a change in these ratings.
The players
Citi
Citigroup's global investment bank whose strategy team publishes tactical asset allocation calls for institutional and retail investors.
The details
Citi cut its view on global and U.S. tech stocks to neutral, citing a sharp drop in AI stock sentiment after the midterm elections. The bank upgraded Europe (ex U.K.) and healthcare to overweight.
Timeline
September 2026: Tech stock sentiment plunged after the midterm elections.
November 9, 2026: Citi published its research note downgrading tech stocks to neutral.
Mid-2027: Citi predicts the Topix will reach 5,000 and the MSCI emerging markets index will reach 2,050.
Market Dynamics
The Nasdaq is trading at forward valuations last seen in March 2020, placing the current tech pullback alongside that earlier market low. Citi's shift toward defensive sectors and Europe reflects a rotation that has favored cyclical-to-defensive positioning over the past month.
Investors with exposure to U.S. and global tech may see their allocations shift if they follow Citi's neutral rating. Those looking at European or healthcare equities should weigh Citi's overweight calls against their own risk tolerance.
The takeaway
Tactical sector ratings like Citi's are short-term views, so investors should check them against their own time horizon and portfolio mix before acting. Defensive and regional rotations can reverse quickly if earnings expectations change.
Further reading
For more on how analysts rate individual equities, see our Stock Picks section.
Live Poll
Are you planning to move any of your investments out of tech stocks soon?
